China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dual-Target Transcranial Magnetic Stimulation of the Orbitofrontal Cortex and Cerebellu... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study of moderate to moderately severe cancer pain'. The following are the oth... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Observational Study of Assessing Neurological State and Predicting Recovery of Consc... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of the Efficacy and Safety of Tegileridine and Sufentanil for Postoperative ... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Combination of APG-2575, Olverembatinib (HQP1351), Liposome Mitoxantrone and Homoharrin... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diagnostic Model for Diabetic Nephropathy Based on Multimodal AI: An Observational Clin... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The multicenter deep learning model for differentiating central lung cancer from atelec... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of remimazolam bridging or sevoflurane-maintained deep anesthesia extubation on ... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mn/QD-SAC–Guided NIR-IIb Imaging and Antioxidant Therapy for Ischemia–Reperfusion Injur... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Safety, T... Read More